Pesquisar
Cellectis SA
CLLSAdicionar à lista de desejos
1.380USD
+0.270+24.32%
Fechamento 11-11 16:00（ET）
139.01MValor de mercado
PerdaP/L TTM
Após o expediente 19:53 (ET)1.460USD+0.110+8.15%
Após o expediente 19:53 (ET)Sobre o Cellectis SA Empresa
Cellectis SA is a France-based company active in the field of genome engineering and genomic surgery. The Company specializes in the research, development, and commercialization of rational genome engineering technologies. The Company develops immunotherapies that aim to force the immune system to target and eradicate cancer cells. It has developed an expertise in combining meganucleases with engineered targeting Deoxyribonucleic Acid (DNA) matrices into Meganuclease Recombination Systems (MRS), used for gene excision, correction or replacement. Cellectis SA markets its technologies mainly for use in the research field, in pharmaceutical drug discovery programs, in the agronomics, bioproduction, and biotherapeutics fields. Cellectis SA operates several subsidiaries. The Company operates in France and the United States, among others.
Cellectis SA Perfil
Código da empresaCLLS
Nome da EmpresaCellectis SA
Data de listagemFeb 06, 2007
CEOSourdive (David J.D)
Número de funcionários224
Tipo de títulosDepository Receipt
Fim do ano fiscalFeb 06
Endereço8, rue de la Croix Jarry
CidadePARIS
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísFrance
Código postal75013
Telefone33181691600
Sitehttps://www.cellectis.com/
Código da empresaCLLS
Data de listagemFeb 06, 2007
CEOSourdive (David J.D)
Executivos da empresa Cellectis SA
Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Steven (Steve) Doares, Ph.D.
Dr. Steven (Steve) Doares, Ph.D.
Senior Vice President - US Manufacturing
Senior Vice President - US Manufacturing
--
--
Mr. Andre C. Muller
Mr. Andre C. Muller
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. Tyrell J. Rivers, Ph.D.
Dr. Tyrell J. Rivers, Ph.D.
Non-Executive Director
Non-Executive Director
--
--
Mr. Marc Dunoyer
Mr. Marc Dunoyer
Non-Executive Director
Non-Executive Director
--
--
Dr. Adrian Kilcoyne, M.D.
Dr. Adrian Kilcoyne, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Dr. Cecile Chartier, Ph.D.
Dr. Cecile Chartier, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. Axel-Sven Malkomes
Mr. Axel-Sven Malkomes
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. Donald A. Bergstrom, M.D., Ph.D.
Dr. Donald A. Bergstrom, M.D., Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. Jeanpierre (JP) Garnier, M.D., Ph.D.
Dr. Jeanpierre (JP) Garnier, M.D., Ph.D.
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
--
--
Ms. Kyung Nam-Wortman
Ms. Kyung Nam-Wortman
Chief Human Resources Officer, Executive Vice President
Chief Human Resources Officer, Executive Vice President
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Steven (Steve) Doares, Ph.D.
Dr. Steven (Steve) Doares, Ph.D.
Senior Vice President - US Manufacturing
Senior Vice President - US Manufacturing
--
--
Mr. Andre C. Muller
Mr. Andre C. Muller
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. Tyrell J. Rivers, Ph.D.
Dr. Tyrell J. Rivers, Ph.D.
Non-Executive Director
Non-Executive Director
--
--
Mr. Marc Dunoyer
Mr. Marc Dunoyer
Non-Executive Director
Non-Executive Director
--
--
Dr. Adrian Kilcoyne, M.D.
Dr. Adrian Kilcoyne, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Dr. Cecile Chartier, Ph.D.
Dr. Cecile Chartier, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Perguntas frequentes
Quem são os cinco principais acionistas de Cellectis SA?
Os cinco principais acionistas de Cellectis SA são: Dr. Andre Choulika, Ph.D.
Quantas instituições possuem ações da Cellectis SA (CLLS)?
Em 2026Q1, 77 instituições possuíam ações da Cellectis SA, com valor de mercado aproximado de 12.30M, representando 17.00% do total de ações. Em comparação com 2025Q4, a participação institucional aumentou em -5544701.00.